Given the high degree of tumor plasticity, it is evident that different selective pressures, environmental and experimental stimuli will bring about distinct changes in the TME and EDB-FN expression, which would in turn influence the clinical outcomes of EDB-FN-targeted imaging and therapeutic interventions. This evidence concerns the gene FN1 and neoplasm.